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This study was conducted on 175 one day old broiler chicks in order to observe in vivo pathogenicity of 
hydropericardium hepatitis syndrome (Angara disease). Chicks were grouped into A (25 chicks; reared 
at the Poultry Research institute (PRI), Rawalpindi) and  B groups (150 chicks; reared at National 
Veterinary Laboratories (NVL) Islamabad in poultry rearing units). Feed and water were provided ad-
libitum to all the birds in both groups. The LD50  (lethal dose 50) of the virus was determined at the age of 
26 days of broiler chickens divided into sub-groups a, b, c, d and e (each having 5 birds). The LD50 titre 
of the viral suspension (10%) was prepared from liver extract and determined as 10
-2.5
 per ml. During the 
study, potency of the vaccines was determined by vaccinating 150 chicks of sub-group k, l, m, n and o 
(each having 30 birds) with a dose of 0.2 ml. The vaccinated and non-vaccinated chicks of sub-groups 
were challenged with viral dose of 2 ml at day 17 post-vaccination to know the protection potency of the 
vaccines. No chick showed clinical manifestation of disease up to five days post challenge. On the 6th 
day post challenge, all the chicks were slaughtered and subjected to postmortem. Some of the chicks 
showed the lesions of hydropericarium. Histopathological findings of liver of all sub-groups revealed 
different stages of necrosis, cloudy swelling, liquefactive necrosis, cytoplasmic blabing, fatty 
degeneration and intranuclear inclusion bodies of virus. 
 





Hydropericardium hepatitis syndrome (HHS) was first 
recognized in broiler flocks in Angara village near Karachi 
Metropolitan City of Pakistan, in the late 1987 (Jaffery, 
1988). Since the disease emerged in this specific 
geographic area, HHS was initially referred to as “Angara 
Disease”. The disease is caused by an avian adenovirus 
serotype-iv in Pakistan. This virus is responsible for 
development of intranuclear inclusion bodies in the cells 
of liver, pancreas and kidneys. The syndrome was 
spread in the densely populated broiler growing areas all 
over the country within six months. The outbreaks of HHS 
were also recorded in Mexico in 1989 in the high density 
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pathogenicity and vaccine development was conducted 
by Ahmed et al. (1989), Anjum et al. (1989), Cheema et 
al. (1989) and Khawaja et al. (1988). The formalinized 
vaccines including aqua base liver organ (ABLO) and oil 
base tissue culture (OBTC) were developed for the 
control of the syndrome (Chishti et al., 1989; Afzal and 
Ahmed, 1990; Ahmed et al., 1990, 1991). Both types of 
vaccines were reported to provide 100% protection in 
vaccinated flocks (Ahmed et al., 1990). The objective of 
this study was to evaluate the pathogenicity of the recent 
field isolate of avian adenovirus.  
 
 
MATERIALS AND METHODS 
 
Rearing of chicks 
 
A total of 175, day old  quality  broiler  chicks  were  purchased from 




Table 1. Angara disease vaccines prepared from chicken liver organ and used for the study. 
 
Subgroups 
of chick  
Vaccines 
used 















k ADVac-I 20 37  0.20 2  S/C S/C  30 
l ADVac-II 20 37  0.20 2  S/C S/C  30 
m ADVac-III 20 37  0.20 2  S/C S/C  30 















the market and divided into two groups (A and B), each having 25 
and 150 chicks, respectively.  Chicks in group A (25) were reared at 
Poultry Research Institute (PRI), Rawalpindi, and used to determine 
the biological titre, that is, LD50 of the virus suspension while chicks 
in group B (150) were reared at National Veterinary Laboratories 
(NVL) Islamabad in poultry rearing units and used for vaccine 
potency testing. Feed and water were provided ad libitum to all the 
birds in both groups. Blood samples for determination of antibody 
titres  were collected from live birds at 0, 7, 14 and 28 days of age 
and tissue samples were collected from chicks after postmortem of 
the died birds. 
 
 
Procurement of Angara disease vaccines 
 
Four commercially available Angara disease vaccines were 
selected and purchased from the market and subjected to sterility 
and potency testing. Their brand names were kept confidential and 
granted codes as AD Vac-I, AD Vac-II, AD Vac-III and AD Vac-IV 
for study purpose. 
 
 
Procurement of Angara disease virus  
 
Ten percent infectious Angara disease liver suspension was 
obtained from the Angara Disease Vaccine Production Laboratory, 
Disease Section, Poultry Research Institute, Murree Road, 
Rawalpindi. This virus suspension was used to determine the 




Determination of biological titre (LD50) of Angara disease (AD) 
virus 
 
At the age of 26 days, the chicks in group A were  divided into sub 
groups, that is, a, b, c, d and e each having five chicks and the 
biological titre, that is, lethal dose for 50% (LD50) of the virus 
suspension (10% infectious liver suspension) per 1 ml was 
determined. Ten fold dilution of virus suspension was prepared in 




 dilution. 1 ml 











was injected subcutaneously into five chicks of each sub group of a, 
b, c, d and e, respectively. Mortality was observed up to seven days 
post injection. Dead and survived birds in each group were 
counted. LD50 was calculated by the method described by Reed 
and Muench (1938). 
Potency test                         
 
At the age of 20 days, the chicks in group B were divided into five 
sub-groups, each having 30 chicks, named k, l, m, n, and o and 
vaccinated with ADVac-I, ADVac-II, ADVac-III and ADVac-IV, 
respectively, except chicks in subgroup o which were kept as non-
vaccinated control. Route and dose of vaccination was adopted 
according to the manufacturer’s instructions (Table 1). Vaccine 
potency was tested by challenge protection. Ten chicks of subgroup 
k, l, m, n and o were subjected to challenge protection by 2 ml of 
10% infectious virus suspension. These chicks were observed for 





All survived chicks of sub group k, l, m, n and o were subjected to 
post mortem examination after slaughtering at the age of day 42. 
The tissue block of liver (~ 4 to 5 mm size) representing the 
pathological lesion, periphery, line of demarcation and normal area 
were incised and obtained for routine histopathology. Each tissue 
block was placed in 10% formalin (8 to 12 h) for hardening and 
fixation/preservation, and dehydrated in series of ascending grades 
of alcohol, that is, 30 (2 h),  50 (2 h), 70 (2 h), 80 (1 h), 95 (2 h), 95 
(1 h), 100 (1 h) and 100% (1 h). After dehydration, the tissue blocks 
were passed from the two fresh changes of xylene I (1 h) and 
xylene II (2 h) for dealcoholization or clearing. Then, blocks were 
placed in the melted paraffin (62°C) in the paraffin oven (6 h) for 
infiltration. The embedding/blocking of tissue blocks were done in 
paraffin wax and sectioned using microtome. Before staining, 
specimen tissue section was deparaffinized with xylene I (5 min) 
and xylene II (5 min) and rehydrated through decreasing grade of 
alcohol, that is, absolute (3 min), 90 (3 min), 80 (3 min),  70% (3 
min), distilled water (few dips), washed in tap water and rinsed in 
distilled water. After that, it was stained with the routine procedure 
of Haematoxyline and Eosin staining method.  
 
 




Determination of lethal dose 50 (LD50) of Angara 
disease virus suspension 
 
Biological   titre   (LD50)   of   the   viral   suspension   was 









Number of chicks 
inoculated 
Number of 
dead chick  
Number of 
survived chick  
Cumulative 





 5 5 0 12/12 100 
b 10
-2
 5 3 2 7/9 60 
c 10
-3
 5 2 3 4/7 40 
d 10
-4
 5 1 4 2/6 20 
e 10
-5




Table 3. Gross pathological lesions recorded after challenge dose of viral suspension inoculated in chicks. 
  
Sub-groups of chick Vaccines administered  Postmortem lesion 
k AD Vac-I 
Five birds with lesions on liver, hydronephrosis and water 
around heart (yellow colour).  
l AD Vac-II 
Three birds with lesions on liver, hydronephrosis and 
water around heart (yellow colour). 
m AD Vac-III 
Four birds with lesions on liver, hydronephrosis and 
water around heart (yellow colour). 
n AD Vac-IV 
Onebird with lesions on liver, hydronephrosis and water 
around heart (yellow colour). 
O Non-vaccinated 
Seven birds with lesions on liver, hydronephrosis and 




calculated, and the results are depicted in Table 2. 
Chicks in sub groups a, b, c, d and e (5, 3, 2, 1 and 1, 
respectively) died and 0, 2, 3, 4 and 4, respectively 
survived. The LD50 titre of the 10% viral suspension 
prepared from liver filtrate was found to be 10
-2..5
 per ml in 
26 days old broiler chicks. Lesions recorded in the dead 
chicks were representative of typical field cases of 
Angara disease (hydropericardium syndrome). However, 
the result of this findings is comparatively different from 
previously reported findings, that is, 1 × 10
5 
LD50/ml 
(Ahmed et al., 1989) and 4 × 10
4 
LD50/ml (Ahmed, 1989). 
The reduction in virulence of virus may be due to 
extensive vaccination in the field as (Ahmed and Hasan, 
2004) determined; the biological titre, that is, LD50  of the 
20% viral filtrate as 1 × 10
1.1
/ ml inoculated 
subcutaneously in 25 days old broiler chicks. Biological 
titre, that is, LD50 of viral suspension as 1 × 10
1.1
/ml 
inoculated sub-cutaneously in 28 days old broiler chicks 
was reported by Ahmed (1999). However, Mashkoor et 





Vaccine potency testing 
 
Vaccine potency testing was performed by challenge 
protection test and antibody titration after vaccination of 
chicks of sub-groups k, l, m and n. Chicks of sub-group o 
were kept as non-vaccinated control. All the vaccinated 
(sub-groups k, l, m and n) and non-vaccinated (group o) 
chicks were subjected to challenge protection test 17 
days post vaccination. No bird (vaccinated and/or non-
vaccinated) died or showed clinical manifestation of 
disease up to five days post challenge. In previously 
reported works, the challenge protection test was 
performed in the chicks aged between 25 and 30 days 
(Ahmed, 1989; Ahmed and Hasan, 2004; Mashkoor et al., 
1994), but in this study, the chicks were aged 37 days at 
the time of challenge protection. Moreover, the biological 
titre, that is, LD50 of the viral suspension was determined 
in the chicks at the age of 25 days in the study. This may 
be one of the reasons for failure of mortality in control 
sub-group o as well as in vaccinated sub-groups k, l, m 
and n. On the 6th day post challenge, all chicks of sub-
groups k, l, m, n and o were slaughtered and subjected to 
post mortem. Some chicks from sub-group k, l, m, n and 
o showed lesions of hydropericardium, which are detailed 
in Table 3. These findings proved that the injected virus 





On day 6th post challenge, the survived chicks of sub-
groups of k, l, m, n and o were slaughtered to observe 
the postmortem lesions as already described. The tissues 
were collected for histopathological observations. The 
histopathological findings in liver tissue of the chicks of 
sub-group k, l, m, n and o are as follows:  




Table  4. Number of inclusion bodies histopathologically recorded in 
different sub-groups of chicks post challenge. 
 
Treatment group 
Inclusion bodies per 
high field (PHF) 

























   



















Histopathological findings   
 
Hepatocytes of liver tissue sub-group k showed 
basophilic intranuclear inclusion bodies of varied sizes 
and numbers depending upon the intensity of inclusion 
bodies produced in hepatocytes. Hepatocytes showed 
varied stages of necrosis (N), cloudy swelling (S) and 
liquefactive necrosis. Necrotic cells showed free nuclei 
(F), cytoplasmic blabing, and fatty degeneration as com-
pared with the number of inclusion bodies present in 
hepatocytes of this sub-group as shown in Table 4 and 
Figure 1.  
The number of inclusion bodies produced in sub-group 
I is shown in Table 4. However, the main pathological 
changes observed were basophilic intranuclear inclusion 
bodies of varied sizes and numbers depending upon the 
intensity of inclusion bodies produced in hepatocytes. 
Hepatocytes showed varied stages of necrosis (N), 
cloudy swelling (S) and liquefactive necrosis. Necrotic 
cells showed free nuclei (F), cytoplasmic blabing and 
fatty degeneration (Table 4 and Figure 2). 
The number of inclusion bodies produced in sub-group 
m is shown in Table 4 and Figure 3. The main patho-
logical changes observed were basophilic intranuclear 
inclusion bodies of varied sizes and numbers depending 
upon the intensity of inclusion bodies produced in hepa-
tocytes. Hepatocytes showed varied stages of necrosis 
(N), cloudy swelling (S) and liquefactive necrosis. 
Necrotic cells showed free nuclei (F), cytoplasmic blabing 
and fatty degeneration. 
The number of inclusion bodies produced in sub-group 
n is shown in Table 4. The main pathological changes 
observed were basophilic intranuclear inclusion bodies of 
varied sizes and numbers depending upon the intensity 
of inclusion bodies produced in hepatocytes. Hepatocytes 
showed   varying   stages   of   necrosis   (N)  and  cloudy 






Figure 1. Histopathological findings of the vaccinated subgroup-k. Liver hepatocytes showing basophilic 
intranuclear inclusion bodies (A), of experimental inoculated avian adeno virus in the vaccinated 37 
days old commercial broilers. Various sizes of inclusion bodies were noted depending on intensity of 
inclusion bodies produced, sinusoidal space dilated (B), cytoplasmic blabing (C), fatty degeneration (D), 
hepatocytes showing various stages of necrosis (N), cloudy swelling (S), liquefactive necrosis. 






Figure 2. Histopathological findings of the vaccinated subgroup-l. Liver hepatocytes showing 
basophilic intranuclear inclusion bodies (A), of experimental inoculated avian adeno virus in the 
vaccinated 37 days old commercial broilers. Various sizes of inclusion bodies were noted depending 
on intensity of inclusion bodies produced, sinusoidal space dilated (B), cytoplasmic blabing (C), fatty 
degeneration (D), hepatocytes showing various stages of necrosis (N), cloudy swelling (S), 
liquefactive necrosis. Necrosed cells showing free nuclei (F) (stained with H&E stain 6902x). 






Figure 3. Histopathological findings of the vaccinated subgroup-m. Liver hepatocytes 
showing basophilic intranuclear inclusion bodies (A), of experimental inoculated avian 
adeno virus in vaccinated 37 days old commercial broilers. Various sizes of inclusion 
bodies were noted depending on intensity of inclusion bodies produced, sinusoidal space 
dilated (B), cytoplasmic blabing (C), fatty degeneration (D), hepatocytes showing various 
stages of necrosis (N), cloudy swelling (S), liquefactive necrosis. Necrosed cells showing 






Figure 4. Histopathological findings of vaccinated sub-group n. Liver hepatocytes 
showing basophilic intranuclear inclusion bodies (A), of experimental inoculated 
avian adeno virus in vaccinated 37 days old commercial broilers. Various sizes of 
inclusion bodies were noted depending on intensity of inclusion bodies produced, 
sinusoidal space dilated (B), cytoplasmic blabing (C), fatty degeneration (D), 
hepatocytes showing various stages of necrosis (N), cloudy swelling (S), liquefactive 
necrosis. Necrosed cells showing free nuclei (F) (Stained with H&E stain 6902x). 
 
 
swelling (S) (Figure  4). 
Hepatocytes in the control sub-group (o) showed 
basophilic intranuclear bodies that is, highly significant 
when compared with other treatment groups (Table 4). 
The main pathological changes observed were basophilic 
intranuclear inclusion bodies of varied sizes and numbers 






Figure 5. Histopathological findings of unvaccinated sub-group o. Liver hepatocytes showing basophilic 
intranuclear inclusion bodies (A), of experimental inoculated avian adeno virus in vaccinated 37 days old 
commercial broilers. Various sizes of inclusion bodies were noted depending on intensity of inclusion 
bodies produced, sinusoidal space dilated (B), cytoplasmic blabing (C), fatty degeneration (D), 
hepatocytes showing various stages of necrosis (N), cloudy swelling (S), liquefactive necrosis. Necrosed 




depending upon the intensity of inclusion bodies 
produced in hepatocytes. Hepatocytes showed varying 
stages of necrosis (N), cloudy swelling (S) and 
liquefactive necrosis. Necrotic cells showed free nuclei 
(F), cytoplasmic blabing and fatty degeneration (Figure  
5).  
During the study, the histopathological examination of 
the liver tissues of the sub-group k, l, m, n and o showed 
the basophilic intranuclear inclusion bodies, cloudy 
swelling, fatty degeneration, dilated sinusoidal spaces, 
necrosis, cytoplasmic blabing and liquefactive necrosis. 
These findings are in line with the previously reported 
findings of Swati et al. (2000), Fadly and Winterfield 
(1973) and Cubillos et al. (1986) who experimentally 
introduced the infectious agent of hydropericardium in 28 
day old broiler chicks and confirmed the presence of Fowl 
Adeno Virus (FAV) by observing basophilic intra-nuclear 
inclusion bodies in the hepatocytes of all the dead birds. 
However, similar study was also conducted by Fadly and 
Winterfield (1973) who reported that the inclusion body of 
hepatitis and anemia syndrome were caused by 
adenoviruses and these diseases were widespread in 
chicks. The farmers were advised to use quality vaccines 
against Angara disease as the vaccines can provide 
100% protection against the disease if they are given at 
the proper age. 
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